Cargando…

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Prediction of breast cancer response to Neoadjuvant Chemotherapy (NACT) is an urgent need to promptly direct non-responder patients to alternative therapies. Infiltrating T lymphocytes, namely cytotoxic T lymphocytes (CTLs) have been appointed as predictors of response. However, cancer cells have th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saraiva, Diana P., Jacinto, António, Borralho, Paula, Braga, Sofia, Cabral, M. Guadalupe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282034/ https://www.ncbi.nlm.nih.gov/pubmed/30555458 http://dx.doi.org/10.3389/fimmu.2018.02605

Ejemplares similares

Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
por: Saraiva, Diana P., et al.
Publicado: (2021)

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
por: Saraiva, Diana P, et al.
Publicado: (2017)

Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies
por: Saraiva, Diana P., et al.
Publicado: (2020)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses
por: Saraiva, Diana P., et al.
Publicado: (2021)

Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy
por: Osuna-Gómez, Rubén, et al.
Publicado: (2021)

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival
por: Wang, Ruo-Xi, et al.
Publicado: (2022)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
por: Zhu, Jie, et al.
Publicado: (2021)

Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes
por: Costa-García, Marcel, et al.
Publicado: (2019)

Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
por: Joshi, Ila, et al.
Publicado: (2023)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

Cytotoxic Granule Trafficking and Fusion in Synaptotagmin7-Deficient Cytotoxic T Lymphocytes
por: Sleiman, Marwa, et al.
Publicado: (2020)

Circulating Placental Vesicles Carry HLA-DR in Pre-Eclampsia: A New Potential Marker of the Syndrome
por: Tersigni, Chiara, et al.
Publicado: (2021)

Anaplasma phagocytophilum-Related Defects in CD8, NKT, and NK Lymphocyte Cytotoxicity
por: Scorpio, Diana G., et al.
Publicado: (2018)

Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Cytotoxic Granule Exocytosis From Human Cytotoxic T Lymphocytes Is Mediated by VAMP7
por: Chitirala, Praneeth, et al.
Publicado: (2019)

Peripheral Blood Classical Monocytes and Plasma Interleukin 10 Are Associated to Neoadjuvant Chemotherapy Response in Breast Cancer Patients
por: Valdés-Ferrada, Javier, et al.
Publicado: (2020)

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
por: Pérez-Pena, Javier, et al.
Publicado: (2019)

Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time
por: Batista, Marta Vaz, et al.
Publicado: (2021)

Polyoxidonium(®) Activates Cytotoxic Lymphocyte Responses Through Dendritic Cell Maturation: Clinical Effects in Breast Cancer
por: Alexia, Catherine, et al.
Publicado: (2019)

Late Steps in Secretory Lysosome Exocytosis in Cytotoxic Lymphocytes
por: van der Sluijs, Peter, et al.
Publicado: (2013)

Editorial: Mechanisms of lymphocyte mediated cytotoxicity in health and disease
por: Baldari, Cosima T., et al.
Publicado: (2023)

Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Xu, Yuhao, et al.
Publicado: (2022)

Combining Immune-Related Genes For Delineating the Extracellular Matrix and Predicting Hormone Therapy and Neoadjuvant Chemotherapy Benefits In Breast Cancer
por: Liu, Jianyu, et al.
Publicado: (2022)

The CD14(+)HLA-DR(lo/neg) Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
por: Mengos, April E., et al.
Publicado: (2019)

HLA-DR Expression Level in CD8(+) T Cells Correlates With the Severity of Children With Acute Infectious Mononucleosis
por: Wang, Yun, et al.
Publicado: (2021)

Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Lee, Hee Jin, et al.
Publicado: (2013)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)

The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
por: Kim, Hee Yeon, et al.
Publicado: (2019)

An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer
por: Fu, Changfang, et al.
Publicado: (2021)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model
por: Roudier, Jean, et al.
Publicado: (2022)

Standardization of neutrophil CD64 and monocyte HLA-DR measurement and its application in immune monitoring in kidney transplantation
por: Peng, Bo, et al.
Publicado: (2022)

Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy
por: Qiao, Yujin, et al.
Publicado: (2022)

Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
por: Lin, Guang-Tan, et al.
Publicado: (2022)

Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells
por: Rey, Jérôme, et al.
Publicado: (2017)

Selective miRNA inhibition in CD8(+) cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses
por: Madrid-Elena, Nadia, et al.
Publicado: (2022)

Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival
por: Bekbolsynov, Dulat, et al.
Publicado: (2020)

HLA-DR-Positive NK Cells Expand in Response to Mycobacterium Tuberculosis Antigens and Mediate Mycobacteria-Induced T Cell Activation
por: Kust, Sofya A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dp3j2qt93b2l01prhqbcoonfmg